BACKGROUND: Coverage by examinations is a crucial indicator of the future impact on the burden of colorectal cancer (CRC). The study aimed to evaluate coverage by examinations associated with CRC screening and early cancer detection of CRC in the Czech Republic. The burden of CRC was also assessed. METHODS: The novel nationwide administrative registry with individual data (period 2010-19) was used to evaluate coverage by examinations for screening faecal occult blood test and colonoscopy. In the second step, additional examinations for early CRC detection were included in the coverage calculation (complete coverage). Age-specific trends in CRC incidence (period 1977-2018) were investigated using Joinpoint regression. RESULTS: Coverage by screening examinations within recommended interval was around 30%. Complete coverage reached >37% and >50% at the 3-year interval. The coverage by examinations for the non-screening population aged 40-49 years was almost 4% and 5% (most of them were colonoscopies) at the 3-year interval. In age groups aged ≥50 years, we observed a significant annual decline, especially in the 50-69 age group, with recent annual decreases reaching up to 5-7%. The change in trend and the recent decline were also observed in the age group 40-49. CONCLUSIONS: More than half of the target screening population was covered by examinations potentially associated with early detection and subsequent treatment of colorectal neoplasms. The substantial coverage by potentially prophylactic examinations might be an explanation for the considerable decrease in CRC incidence.

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of General Practice 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

Military University Hospital 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. PubMed

Lauby-Secretan B, Vilahur N, Bianchini F, et al.; International Agency for Research on Cancer Handbook Working Group. The IARC perspective on colorectal cancer screening. N Engl J Med 2018;378:1734–40. PubMed PMC

Giorgi Rossi P, Vicentini M, Sacchettini C, et al.Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol 2015;110:1359–66. PubMed

Bucchi L, Mancini S, Baldacchini F, et al.; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study. Br J Cancer 2022;127:541–8. PubMed PMC

Brenner H, , StockC, , Hoffmeister M.. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467. PubMed PMC

Lin JS, , PerdueLA, , Henrikson NB,. et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;325:1978–98. PubMed

Ran T, Cheng CY, Misselwitz B, et al.Cost-effectiveness of colorectal cancer screening strategies-a systematic review. Clin Gastroenterol Hepatol 2019;17:1969–81.e15. PubMed

Bulliard JL, Garcia M, Blom J, et al.Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer. Eur J Cancer 2014;50:434–46. PubMed

Winawer SJ, Zauber AG, Ho MN, et al.Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977–81. PubMed

Zauber AG, Winawer SJ, O'Brien MJ, et al.Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687–96. PubMed PMC

Stock C, Haug U, Brenner H.. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc 2010; 71:366–81.e2. PubMed

Stock C, Ihle P, Schubert I, Brenner H.. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort. Endoscopy 2011;43:771–81. PubMed

Institute of Health Information and Statistics of the Czech Republic: National Register of Reimbursed Health Services (NRRHS) [Internet]. Available at: https://www.uzis.cz/index.php?pg=registry-sber-dat–narodni-registr-hrazenych-zdravotnich-sluzeb (20 November 2022, date last accessed)

Vuik FER, Nieuwenburg SAV, Bardou M, et al.Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68:1820–6. PubMed PMC

Burnett-Hartman AN, Lee JK, Demb J, Gupta S.. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology 2021;160:1041–9. PubMed PMC

Suchanek S, Majek O, Vojtechova G, et al.Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening. Eur J Cancer Prev 2014;23:18–26. PubMed

Senore C, Inadomi J, Segnan N, et al.Optimising colorectal cancer screening acceptance: a review. Gut 2015;64:1158–77. PubMed

Majek O, Ngo O, Danes J, et al.Integration of personalised invitation system to cancer screening programmes in the Czech RepublicOndrej Majek. Eur J Public Health 2016;26(suppl_1).

Institute of Health Information and Statistics of the Czech Republic: Czech National Cancer Registry (CNCR) [Internet]. Available at: http://www.uzis.cz/registry-nzis/nor (5 March 2022, date last accessed)

Dušek L, Mužík J, Kubásek M. Epidemiology of Malignant Tumours in the Czech Republic [Internet]. 2005. Available at: http://www.svod.cz (5 March 2022, date last accessed)

Kim HJ, Fay MP, Feuer EJ, Midthune DN.. Permutation tests for joinpoint regression with applications to cancer rates. Statist Med 2000;19:335–51. PubMed

Corley DA, Jensen CD, Marks AR, et al.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298–306. PubMed PMC

Ngo O, Chloupková R, Suchánek Š, et al.Current results of colorectal cancer screening and potential value of colon capsule endoscopy in the Czech Republic. Gastroent Hepatol 2019;73:387–91.

Wender RC, Brawley OW, Fedewa SA, et al.A blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control. CA Cancer J Clin 2019;69:50–79. PubMed

Ventura L, Mantellini P, Grazzini G, et al.The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 2014;46:82–86. PubMed

Cardoso R, Guo F, Heisser T, et al.Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021;22:1002–13. PubMed

Májek O, Anttila A, Arbyn M, et al.The legal framework for European cervical cancer screening programmes. Eur J Public Health 2019;29:345–50. PubMed